Nephrocare Health Services Limited (NSE:NEPHROPLUS)

India · Delayed Price · Currency is INR

529.25

-2.55 (-0.48%)

At close: Apr 30, 2026

Nephrocare Health Services Earnings Call Transcripts

Fiscal Year 2026

Q3 25/26

Revenue grew 32% YoY in Q3 and 37% for nine months FY 2026, with international business now 41% of revenue. Adjusted EBITDA margin rose to 24.3%, and ROCE is projected to reach 24.7%. Guidance is for 15%-20% revenue CAGR over 3-4 years.

Read full transcript →

Slides Quarterly report

Powered by